Andra AP fonden Buys 9,600 Shares of Cigna Group $CI

Andra AP fonden lifted its stake in shares of Cigna Group (NYSE:CIFree Report) by 640.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,100 shares of the health services provider’s stock after purchasing an additional 9,600 shares during the quarter. Andra AP fonden’s holdings in Cigna Group were worth $3,200,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its position in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the period. Collier Financial purchased a new position in Cigna Group during the third quarter valued at approximately $34,000. NewSquare Capital LLC grew its stake in Cigna Group by 38.8% during the second quarter. NewSquare Capital LLC now owns 143 shares of the health services provider’s stock valued at $47,000 after acquiring an additional 40 shares in the last quarter. Traub Capital Management LLC bought a new stake in Cigna Group during the 2nd quarter worth approximately $48,000. Finally, Access Investment Management LLC purchased a new stake in Cigna Group in the 2nd quarter worth approximately $49,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $289.73 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a fifty day moving average of $279.98 and a 200-day moving average of $284.56. The stock has a market capitalization of $77.39 billion, a price-to-earnings ratio of 13.06, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period in the prior year, the business posted $6.64 earnings per share. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is presently 27.23%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CI. TD Cowen upped their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Guggenheim restated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Monday, February 2nd. Wells Fargo & Company decreased their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Finally, Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.63.

View Our Latest Stock Report on CI

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.